Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
7.69
+0.03 (0.39%)
Jan 26, 2026, 4:00 PM EST - Market closed

Fennec Pharmaceuticals Revenue

Fennec Pharmaceuticals had revenue of $12.46M in the quarter ending September 30, 2025, with 78.69% growth. This brings the company's revenue in the last twelve months to $38.79M, down -21.39% year-over-year. In the year 2024, Fennec Pharmaceuticals had annual revenue of $47.54M with 123.69% growth.

Revenue (ttm)
$38.79M
Revenue Growth
-21.39%
P/S Ratio
5.48
Revenue / Employee
$1,212,188
Employees
32
Market Cap
262.64M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202447.54M26.29M123.69%
Dec 31, 202321.25M19.72M1,284.50%
Dec 31, 20221.54M--
Dec 31, 2021---
Dec 31, 2020170.00K--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Coherus Oncology277.73M
Heron Therapeutics155.10M
Silence Therapeutics25.83M
OmniAb21.09M
Shattuck Labs1.00M
Neurogene925.00K
Abeona Therapeutics400.00K
Revenue Rankings